{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:55:55Z","timestamp":1780628155479,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018765","name":"Shire Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019211","name":"AbbVie Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014554","name":"Janssen Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["THC-135234"],"award-info":[{"award-number":["THC-135234"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["333252"],"award-info":[{"award-number":["333252"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016040","name":"Takeda Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007658","name":"Crohn&apos;s and Colitis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jpsychores.2019.109890","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:29:09Z","timestamp":1575286149000},"page":"109890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Social phobia in immune-mediated inflammatory diseases"],"prefix":"10.1016","volume":"128","author":[{"given":"Ian M.","family":"Reinhorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Sareen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Hitchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jpsychores.2019.109890_bb0005","first-page":"2341","article-title":"Robust association between inflammatory bowel disease and generalized anxiety disorder: findings from a nationally representative Canadian study","volume":"21","author":"Fuller-Thomson","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.jpsychores.2019.109890_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler. J."},{"issue":"Supplement C","key":"10.1016\/j.jpsychores.2019.109890_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jad.2017.02.007","article-title":"Anxiety disorder among rheumatoid arthritis patients: insights from real-life data","volume":"213","author":"Watad","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jpsychores.2019.109890_bb0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychores.2019.109890_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izz045","article-title":"The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease","author":"Lewis","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jpsychores.2019.109890_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1352458506071161","article-title":"Anxiety disorders and their clinical correlates in multiple sclerosis patients","volume":"13","author":"Korostil","year":"2007","journal-title":"Mult. Scler."},{"issue":"23","key":"10.1016\/j.jpsychores.2019.109890_bb0035","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMcp1614701","article-title":"Social anxiety disorder","volume":"376","author":"Leichsenring","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychores.2019.109890_bb0040","first-page":"1","article-title":"Social anxiety disorder: much more than shyness","volume":"11\u2013008","author":"Shields","year":"2005","journal-title":"Statistics Canada Catalogue No."},{"issue":"4","key":"10.1016\/j.jpsychores.2019.109890_bb0045","first-page":"282","article-title":"Social phobia: comorbidity and morbidity in an epidemiologic sample","volume":"49","author":"Schneier","year":"1992","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychores.2019.109890_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12916-017-0889-2","article-title":"The cross-national epidemiology of social anxiety disorder: data from the World Mental Health Survey initiative","volume":"15","author":"Stein","year":"2017","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.jpsychores.2019.109890_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291707001699","article-title":"Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication","volume":"38","author":"Ruscio","year":"2008","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.jpsychores.2019.109890_bb0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1352458508099143","article-title":"Social anxiety in a multiple sclerosis clinic population","volume":"15","author":"Poder","year":"2009","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.jpsychores.2019.109890_bb0065","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1572-0241.2008.01980.x","article-title":"The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders","volume":"103","author":"Walker","year":"2008","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jpsychores.2019.109890_bb0070","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.2196\/resprot.8794","article-title":"A prospective study of the effects of psychiatric comorbidity in immune-mediated inflammatory disease: rationale, protocol and participation","volume":"7","author":"Marrie","year":"2018","journal-title":"JMIR Research Protocols"},{"issue":"Suppl A","key":"10.1016\/j.jpsychores.2019.109890_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jpsychores.2019.109890_bb0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jpsychores.2019.109890_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jpsychores.2019.109890_bb0090","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jpsychores.2019.109890_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.jpsychores.2019.109890_bb0100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jpsychores.2019.109890_bb0105","series-title":"User\u2019s Guide for the Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Research Version - (SCID-I for DSM-IV-TR, November 2002 Revision)","author":"First","year":"2002"},{"issue":"6","key":"10.1016\/j.jpsychores.2019.109890_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychores.2019.109890_bb0115","series-title":"The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease, Inflamm Bowel Dis April 13","author":"Bernstein","year":"2018"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0120","article-title":"The validity and reliability of screening measures for depression and anxiety disorders in rheumatoid arthritis","author":"Hitchon","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2017.12.007","article-title":"The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis","volume":"20","author":"Marrie","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/00365527809182199","article-title":"A comparison of oral prednisolone give as single or multiple daily doses for active protocolitis","volume":"13","author":"Powell-Tuck","year":"1978","journal-title":"Scand. J. Gastroenterol."},{"issue":"8167","key":"10.1016\/j.jpsychores.2019.109890_bb0135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jpsychores.2019.109890_bb0140","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.21649","article-title":"Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice","volume":"64","author":"Anderson","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0145","series-title":"Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory, Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease, Inflammatory Bowel Diseases","author":"Bernstein","year":"2018"},{"issue":"22","key":"10.1016\/j.jpsychores.2019.109890_bb0150","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/WNL.0000000000002174","article-title":"Differences in the burden of psychiatric comorbidity in MS vs the general population","volume":"85","author":"Marrie","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0155","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/acr.23539","article-title":"Increased burden of psychiatric disorders in rheumatoid arthritis","volume":"70","author":"Marrie","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1192\/bjp.176.4.379","article-title":"Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale","volume":"176","author":"Connor","year":"2000","journal-title":"The British Journal of Psychiatry\u202f: The Journal of Mental Science"},{"issue":"4","key":"10.1016\/j.jpsychores.2019.109890_bb0165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eurpsy.2006.12.002","article-title":"Screening social phobia in adolescents from general population: the validity of the Social Phobia Inventory (SPIN) against a clinical interview","volume":"22","author":"Ranta","year":"2007","journal-title":"Eur Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychores.2019.109890_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0022-3956(94)90036-1","article-title":"Reliability and validity studies of the WHO-composite international diagnostic interview (CIDI): a critical review","volume":"28","author":"Wittchen","year":"1994","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.jpsychores.2019.109890_bb0175","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S0033291700035893","article-title":"Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders","volume":"26","author":"Wittchen","year":"1996","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.jpsychores.2019.109890_bb0180","doi-asserted-by":"crossref","DOI":"10.1176\/appi.psy.51.4.338","article-title":"Prevalence and determinants of psychiatric disorders in patients with rheumatoid arthritis","volume":"51","author":"Lok","year":"2010","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.jpsychores.2019.109890_bb0185","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/mpr.1444","article-title":"The regional distribution of anxiety disorders: implications for the global Burden of disease study, 2010","volume":"23","author":"Baxter","year":"2014","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.jpsychores.2019.109890_bb0190","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000006854","article-title":"Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders","author":"Whitehouse","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0195","article-title":"Functional gastrointestinal disorders negatively affect health-related quality of life in MS","author":"Marrie","year":"2019","journal-title":"Neurology: Clinical Practice"},{"issue":"3","key":"10.1016\/j.jpsychores.2019.109890_bb0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpsychores.2009.07.018","article-title":"Social phobia and depression: prevalence and comorbidity","volume":"68","author":"Ohayon","year":"2010","journal-title":"J. Psychosom. Res."},{"issue":"6","key":"10.1016\/j.jpsychores.2019.109890_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.12.045","article-title":"Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease","volume":"14","author":"Mikocka-Walus","year":"2016","journal-title":"Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association"},{"issue":"2","key":"10.1016\/j.jpsychores.2019.109890_bb0210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/rheumatology\/kev306","article-title":"Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial","volume":"55","author":"Matcham","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2019.102117","article-title":"Examining the cross-sectional and longitudinal effects of anxiety sensitivity on indicators of disease severity among patients with inflammatory arthritis","volume":"67","author":"Bernstein","year":"2019","journal-title":"J Anxiety Disord"},{"issue":"11","key":"10.1016\/j.jpsychores.2019.109890_bb0220","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00439-015-1596-8","article-title":"Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS","volume":"134","author":"Wang","year":"2015","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.jpsychores.2019.109890_bb0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2016.146","article-title":"Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond","volume":"42","author":"Michopoulos","year":"2017","journal-title":"Neuropsychopharmacology\u202f: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychores.2019.109890_bb0230","doi-asserted-by":"crossref","first-page":"f2541","DOI":"10.1136\/bmj.f2541","article-title":"Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance","volume":"346","author":"Pilling","year":"2013","journal-title":"BMJ"}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399919309262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399919309262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:10:20Z","timestamp":1777421420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022399919309262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":46,"alternative-id":["S0022399919309262"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2019.109890","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Social phobia in immune-mediated inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychosomatic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychores.2019.109890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109890"}}